Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pyrazinamide measurement |
Component |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing pyrazinamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to pyrazinamide (finding) |
Causative agent (attribute) |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyrazinamide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to pyrazinamide (finding) |
Causative agent (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Pyrazinamide 500 mg oral tablet |
Has precise active ingredient |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isoniazid and pyrazinamide and rifampicin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrazinamide 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyrazinamide 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pyrazinamide 150 mg dispersible oral tablet |
Has precise active ingredient |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyrazinamide 150 mg dispersible oral tablet |
Has basis of strength substance (attribute) |
True |
Pyrazinamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |